| Latest Glaxosmithkline Plc News Headlines |
| Date | Time | Source | |
| 11/21/2008 | 12:25PM | UKREG | Transaction in Own Shares
RNS Number : 7263I
GlaxoSmithKline PLC
21 November 2008
GlaxoSmithKline plc (the 'Company') announces that in accordance with the authority granted by shareholders at the Company's Annual
General Meeting on 21 May 2008 it purchased 1,250,000 of its Ordinary shares of 25 pence each ('shares') on 21 November... More...>> |
| 11/21/2008 | 7:52AM | TFNF | Glance-STOCKS NEWS EUROPE-Pharmas suffer as risk appetite inches back
STOCKS NEWS Reuters
Results diary
Stocks on the move Real-time Equity News
12:08GMT 21Nov2008-European pharmas suffers as risk appetite inches back
------------------------------------------------------------------------
Shares in European... More...>> |
| 11/21/2008 | 7:50AM | TFNF | Glance-STOCKS NEWS EUROPE-Pharmas suffer as risk appetite inches back
STOCKS NEWS Reuters
Results diary
Stocks on the move Real-time Equity News
12:08GMT 21Nov2008-European pharmas suffers as risk appetite inches back
------------------------------------------------------------------------
Shares in European... More...>> |
| 11/21/2008 | 6:01AM | TFNF | UPDATE 1-Glaxo forms Chinese flu vaccine joint venture
LONDON, Nov 21 (Reuters) - GlaxoSmithKline Plc formed a joint venture with
China's Shenzhen Neptunus Interlong Bio-Technique (NBIT) to develop seasonal and
pre-pandemic flu vaccines.
The venture will first target strains of the influenza virus which are
specific to China, Hong Kong and Macau... More...>> |
| 11/21/2008 | 5:21AM | TFNF | BRIEF-GlaxoSmithKline forms Chinese flu vaccine JV
LONDON, Nov 21 (Reuters) - GlaxoSmithKline PLC:
* GSK and Neptunus sign cooperation agreement to form joint venture for the
co-development of flu vaccines in China, Hong Kong and Macau
* Expects to make a cash contribution of approximately US$31 million in
return for a 40% stake in the JV
((London... More...>> |
| 11/21/2008 | 4:57AM | UKREG | Neptunus Joint Venture
RNS Number : 6583I
GlaxoSmithKline PLC
21 November 2008
Issued: Friday 21 November 2008, London UK - LSE Announcement
GSK and Neptunus sign cooperation agreement to form joint venture for the co-development of flu vaccines in China, Hong Kong and Macau
GlaxoSmithKline (GSK... More...>> |
| 11/20/2008 | 8:44PM | TFNF | PRESS DIGEST - China - Nov 21
BEIJING/SHANGHAI, Nov 21 (Reuters) - Chinese newspapers available in Beijing
and Shanghai carried the following stories on Friday. Reuters has not checked
the stories and does not vouch for their accuracy.
CHINA SECURITIES JOURNAL
-- Toyota Motor expects to sell 600,000 cars in China this... More...>> |
| 11/20/2008 | 7:27PM | TFNF | UPDATE 1-Glaxo wins U.S. approval for platelet drug
NEW YORK, Nov 20 (Reuters) - GlaxoSmithKline Plc said on Thursday its new
platelet-boosting drug, Promacta, was granted accelerated approval by the U.S.
Food and Drug Administration.
Promacta, also known by the chemical name eltrombopag, is approved for
the treatment of patients with chronic immune thrombocytopenic... More...>> |
| 11/20/2008 | 7:09PM | TFNF | Glaxo wins U.S. approval for platelet drug
NEW YORK, Nov 20 (Reuters) - GlaxoSmithKline Plc said on Thursday its new
platelet-boosting drug, Promacta, had been granted accelerated approval by the
U.S. Food and Drug Administration.
Promacta, also known by the chemical name eltrombopag, is approved for
the treatment of patients with chronic immune... More...>> |
| 11/20/2008 | 12:22PM | UKREG | Transaction in Own Shares
RNS Number : 6315I
GlaxoSmithKline PLC
20 November 2008
GlaxoSmithKline plc (the 'Company') announces that in accordance with the authority granted by shareholders at the Company's Annual
General Meeting on 21 May 2008 it purchased 1,020,000 of its Ordinary shares of 25 pence each ('shares') on 20 November... More...>> |
| 11/20/2008 | 11:00AM | TFNF | UPDATE 1-Glaxo buys AstraZeneca OTC painkiller unit
LONDON, Nov 20 (Reuters) - GlaxoSmithKline has bought AstraZeneca's
Sweden-focussed over-the-counter (OTC) painkiller unit AZ Tika for 146 million
pounds ($216.6 million).
The acquisition reinforces Glaxo's drive to expand its consumer
healthcare business, and reflects the commitment of new Chief Executive... More...>> |
| 11/20/2008 | 9:57AM | TFNF | BRIEF-GlaxoSmithKline buys AstraZeneca's Alvedon
LONDON, Nov 20 (Reuters) - GlaxoSmithKline PLC:
* To strengthen OTC analgesic business with acquisition of Alvedon from
AstraZeneca
* Will acquire AZ Tika, a company wholly owned by Astrazeneca, for
approximately £146 million
((London Equities Newsroom; +44 20 7542 7717... More...>> |
| 11/20/2008 | 9:38AM | UKREG | Acquisition of AstraZeneca Tika SNC
RNS Number : 6004I
GlaxoSmithKline PLC
20 November 2008
Issued: Thursday 20th November 2008, London UK - LSE announcement
GSK to strengthen OTC analgesic business with acquisition of Alvedon
GlaxoSmithKline (GSK) today announced that it has entered into an agreement with AstraZeneca... More...>> |
| 11/20/2008 | 9:31AM | TFNF | CORRECTED-Dutch pick Glaxo's Cervarix for vaccine programme
LONDON, Nov 20 (Reuters) - The Dutch government has selected
GlaxoSmithKline's cervical cancer vaccine Cervarix for the country's national
immunisation programme, the company said on Thursday.
The vaccine was chosen over rival Gardasil, which is produced by Merck &
Co and marketed in the EU as part of... More...>> |
| 11/20/2008 | 7:37AM | TFNF | Dutch pick Glaxo's Cervarix for vaccine programme
LONDON, Nov 20 (Reuters) - The Dutch government has selected
GlaxoSmithKline's cervical cancer vaccine Cervarix for the country's national
immunisation programme, the company said on Thursday.
The vaccine, marketed in the EU under a joint venture with
Sanofi-Aventis, was chosen over Gardasil, which is... More...>> |
| 11/20/2008 | 7:33AM | TFNF | UPDATE 3-AstraZeneca to cut jobs, halts generic asthma drug
By Mark Potter and Niklas Pollard
LONDON/STOCKHOLM, Nov 20 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc
plans 1,400 job cuts and is closing three plants around Europe as it joins
others in the sector tackling increased competition and cost pressures.
AstraZeneca also said on Thursday that... More...>> |
| 11/20/2008 | 7:32AM | TFNF | UPDATE 3-AstraZeneca to cut jobs, halts generic asthma drug
By Mark Potter and Niklas Pollard
LONDON/STOCKHOLM, Nov 20 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc
plans 1,400 job cuts and is closing three plants around Europe as it joins
others in the sector tackling increased competition and cost pressures.
AstraZeneca also said on Thursday that... More...>> |
| 11/20/2008 | 6:49AM | TFNF | FACTBOX-Job cuts by large companies in Britain
LONDON, Nov 20 (Reuters) - British companies are cutting jobs as they
respond to the global economic downturn. Following is a list of some of the
biggest names announcing major job cuts since Sept. 31 (in alphabetical order):
* AstraZeneca
The Anglo-Swedish drugmaker said on Nov. 20... More...>> |
| 11/20/2008 | 5:14AM | TFNF | UPDATE 2-AstraZeneca to cut jobs, halts generic asthma drug
By Mark Potter and Niklas Pollard
LONDON/STOCKHOLM, Nov 20 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc
plans 1,400 job cuts and is closing three plants around Europe as it joins
others in the sector tackling increased competition and cost pressures.
AstraZeneca also said it had also won a... More...>> |
| 11/19/2008 | 12:25PM | UKREG | Transaction in Own Shares
RNS Number : 5317I
GlaxoSmithKline PLC
19 November 2008
GlaxoSmithKline plc (the 'Company') announces that in accordance with the authority granted by shareholders at the Company's Annual
General Meeting on 21 May 2008 it purchased 600,000 of its Ordinary shares of 25 pence each ('shares') on 19 November... More...>> |